The Treatment of Metastatic Prostate Cancer Using Hormonal Therapy: A Narrative Review

References (37)

1. 1 Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer [DOI]
2. 2 Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial [DOI]
3. 3 Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy [DOI]
4. 4 Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial [DOI]
5. 5 Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer [DOI]
6. 6 [177Lu]Lu-PSMA-617 versus cabazitaxel in patients with metastatic castration-resistant prostate cancer (TheraP): a randomised, open-label, phase 2 trial [DOI]
7. 7 Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer: Long-Term Survival Analysis of the Randomized Phase III E3805 CHAARTED Trial [DOI]
8. 8 Enzalutamide in Men with Nonmetastatic, Castration-Resistant Prostate Cancer [DOI]
9. 9 Prostate cancer progression after androgen deprivation therapy: mechanisms of castrate resistance and novel therapeutic approaches [DOI]
10. 10 Androgen deprivation therapy: progress in understanding mechanisms of resistance and optimizing androgen depletion [DOI]
11. 11 Adverse Events Associated With Testosterone Replacement in Middle-Aged and Older Men: A Meta-Analysis of Randomized, Placebo-Controlled Trials [DOI]
12. 12 Shifting the Paradigm of Testosterone and Prostate Cancer: The Saturation Model and the Limits of Androgen-Dependent Growth [DOI]
13. 13 Androgen receptor splice variant-7 expression emerges with castration resistance in prostate cancer [DOI]
14. 14 Androgen deprivation therapy in the treatment of advanced prostate cancer.
15. 15 Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer [DOI]
16. 16 TESTOSTERONE REPLACEMENT THERAPY AFTER PRIMARY TREATMENT FOR PROSTATE CANCER [DOI]
17. 17 Epidemiology, Etiology, Diagnosis and Treatment of Prostate Cancer [DOI]
18. 18 Testosterone Replacement Therapy Following Radical Prostatectomy [DOI]
19. 19 Src Family Kinase Activity Is Up-Regulated in Hormone-Refractory Prostate Cancer [DOI]
20. 20 Cellular and Molecular Mechanisms Underlying Prostate Cancer Development: Therapeutic Implications [DOI]
21. 21 Serum Testosterone and Dihydrotestosterone and Prostate Cancer Risk in the Placebo Arm of the Reduction by Dutasteride of Prostate Cancer Events Trial [DOI]
22. 22 Constitutively active androgen receptor splice variants AR-V3, AR-V7 and AR-V9 are co-expressed in castration-resistant prostate cancer metastases [DOI]
23. 23 Androgen receptor targeted therapies in castration‐resistant prostate cancer: Bench to clinic [DOI]
24. 24 Androgen Receptor-Dependent Mechanisms Mediating Drug Resistance in Prostate Cancer [DOI]
25. 25 A Review of the Pathophysiological Mechanisms Underlying Castration-resistant Prostate Cancer [DOI]
26. 26 Testosterone therapy in hypogonadal men and potential prostate cancer risk: a systematic review [DOI]
27. 27 Height and Prostate Cancer Risk: A Large Nested Case-Control Study (ProtecT) and Meta-analysis [DOI]
28. 28 Systematic Review and Meta-analysis of the Survival Outcomes of First-line Treatment Options in High-risk Prostate Cancer [DOI]
29. 29 LHRH Agonists for the Treatment of Prostate Cancer: 2012.
30. 30 An update on the use of degarelix in the treatment of advanced hormone-dependent prostate cancer [DOI]
31. 31 Androgen receptor co-regulation in prostate cancer [DOI]
32. 32 The role of LHRH antagonists in the treatment of prostate cancer.
33. 33 SEOM clinical guidelines for the treatment of advanced prostate cancer (2020) [DOI]
34. 34 Comparison of single-agent androgen suppression for advanced prostate cancer.
35. 35 Questioning the evidence behind the Saturation Model for testosterone replacement therapy in prostate cancer [DOI]
36. 36 VISION trial [DOI]
37. 37 Clinical and Translational Oncology [DOI]

Cited by 0

No indexed citations yet.

Related research

• Evaluation of the Outcome of Interventions for Thoracic Endometriosis Syndrome at a Tertiary Level Health Institution in Southern Nigeria — shares topic coverage
• Clinicopathological Profile of Breast Cancer in Rural Central India: A Five-year Retrospective Case Series from Gondia District — shares topic coverage
• Anxiety and Depression among Breast Cancer Patients: A Prospective Study in a Tertiary Care Hospital — shares topic coverage
• Prostate Cancer in Cameroon: Epidemiological Trends, Diagnostic Challenges, Therapeutic Constraints, and Emerging Opportunities: A Systematic Review — shares topic coverage
• Epigenetic Drivers of Resistance to Androgen Deprivation in Prostate Cancer: A Critical Appraisal of Mechanisms, Evidence Quality and Therapeutic Translation — shares topic coverage